• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK MODIFIED ORIFICE VALVED CONDUIT; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK MODIFIED ORIFICE VALVED CONDUIT; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number HC15016
Device Problems Break (1069); Calcified (1077); Crack (1135); Hole In Material (1293); Occlusion Within Device (1423); Torn Material (3024)
Patient Problem Insufficiency, Valvular (1926)
Event Date 03/01/1995
Event Type  Injury  
Event Description
Medtronic received information from a 1995 journal article that compared the long term results of a typical valve replacement and the biological valves used for extra-cardiac conduit valves from a single facility in (b)(6).The article compared two sets of populations: adults who underwent a typical bioprosthetic heart valve replacement and children who had a conduit valve device implanted to treat congenital cardiac diseases.The article discussed 25 patients with extra-cardiac conduit valve repair surgeries between the right ventricle and pulmonary arteries to treat various congenital cardiac diseases.16 of the 25 devices were medtronic bioprosthetic valved conduits; the remaining nine were devices from two other manufacturers.The primary observations for the entire children¿s population was that device dysfunction was mainly related to stenotic lesions due to fusion or adhesion of the device¿s commissures and/or calcification of the device cusps.The article reported that 12 medtronic devices were explanted.A graphic in the article showed the following five types of device issues specific to explanted medtronic devices from the combined adult mitral device and children conduit populations (but did not specify how many of each of the occurrences were for the 12 devices in this report): adhesion of the commissural region, calcification, mobility loss, cusp atrophy, and cuspal cracks/perforations.Associated observations of regurgitation associated with the device issues ranged from none to severe regurgitation.The freedom from reoperation for the children population ranged from 92.9% at five years to 8.5% at nine years, and 0% at 9 years and 3 months (the longest time of implant of the children population at the time of the article).The average age of the 25 patients in this report was six years old with an average of age 5.2 for patients with medtronic devices in this population.Their devices were implanted from (b)(6) to (b)(6), with an average follow-up period of (b)(6).The conduit valve sizes ranged from 12 mm to 25 mm.There were no deaths or post-operative complications reported for the 12 patients whose devices were explanted and replaced.Without device-specific information available in the article, the device model reported here represents the most likely model that was available for implant at the time.Separate reports have been filed on a reported re-operative death and device malfunctions observed from the adult population.
 
Manufacturer Narrative
Following a search of the fda maude database and medtronic¿s databases, it appears the issues included in this article were not previously reported either as individual or journal article complaints.Without device- or patient-identifying information, it could not be determined if any of the explanted devices had been returned to medtronic for analysis.(b)(4).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK MODIFIED ORIFICE VALVED CONDUIT
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4271853
MDR Text Key5003559
Report Number2025587-2014-00922
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P790007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,foreign,health profe
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/27/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/23/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHC15016
Device Catalogue NumberHC15016
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/27/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age00043 YR
-
-